| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.01 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |